Cinedigm Corp. (CIDM) Reaches $1.82 52-Week High; Gluskin Sheff & Assoc Has Lowered Pfizer (PFE) Position

Cinedigm Corp. (NASDAQ:CIDM) Logo

Gluskin Sheff & Assoc Inc decreased Pfizer Inc (PFE) stake by 1.43% reported in 2018Q4 SEC filing. Gluskin Sheff & Assoc Inc sold 11,373 shares as Pfizer Inc (PFE)’s stock declined 4.08%. The Gluskin Sheff & Assoc Inc holds 785,715 shares with $34.30 million value, down from 797,088 last quarter. Pfizer Inc now has $231.95B valuation. The stock increased 1.43% or $0.59 during the last trading session, reaching $41.78. About 70.94M shares traded or 168.10% up from the average. Pfizer Inc. (NYSE:PFE) has risen 20.88% since March 15, 2018 and is uptrending. It has outperformed by 16.51% the S&P500. Some Historical PFE News: 18/05/2018 – AstraZeneca sales hit by generic competitors to Crestor statin; 23/03/2018 – GSK pullout puts sale of Pfizer consumer health unit in doubt; 10/04/2018 – FDA: Abbreviated New Drug Application (ANDA): 060657 Company: PFIZER; 11/03/2018 – Bristol-Myers: Eliquis Associated With Lower Rates of Stroke, Major Bleeding Than Patients Receiving Rivaroxaban or Dabigatran; 26/04/2018 – “The Future of Getting Old” – With Old Age, New Possibilities; 23/04/2018 – PFIZER RECEIVED A COMPLETE RESPONSE LETTER; 23/04/2018 – Pfizer: FDA Highlights Need for Additional Technical Info; 30/05/2018 – FDA approves Pfizer’s Xeljanz to treat ulcerative colitis; 30/05/2018 – Pfizer: XELJANZ, an Oral Therapy, Is First and Only JAK Inhibitor Approved in U.S. for This Patient Population; 19/04/2018 – ASEMBIA CLIENTS GAIN ACCESS TO PFIZER ONCOLOGY PRODUCTS

The stock of Cinedigm Corp. (NASDAQ:CIDM) hit a new 52-week high and has $1.97 target or 8.00% above today’s $1.82 share price. The 7 months bullish chart indicates low risk for the $64.93M company. The 1-year high was reported on Mar, 15 by Barchart.com. If the $1.97 price target is reached, the company will be worth $5.19 million more. The stock increased 11.66% or $0.19 during the last trading session, reaching $1.82. About 488,740 shares traded or 391.14% up from the average. Cinedigm Corp. (NASDAQ:CIDM) has risen 21.60% since March 15, 2018 and is uptrending. It has outperformed by 17.23% the S&P500. Some Historical CIDM News: 25/04/2018 – Cinedigm Partners With Gatherer Entertainment, Disrupting Traditional TV Viewing by Launching a Female-First, Curated Over-The-; 07/05/2018 – CINEDIGM BUYS FEATURE DOCUMENTARY LOGAN’S SYNDROME; 25/04/2018 – Cinedigm, JungoTV and Korean Broadcast Powerhouse SBS Partner to Launch HALLYPOP™ Digital-First Network Celebrating Asian Pop; 09/04/2018 – Cinedigm’s 24/7 ESports-Focused WHAM Network Launches on XUMO, Twitch, and The Web Today; 20/04/2018 – Cinedigm Signs Cooperation Agreements with Key Chinese Entertainment Partners; 11/04/2018 – Cinedigm to Participate at the Beijing Film Festival with Three Industry Presentations & Signing Ceremony for Cooperation Agree; 11/04/2018 – Cinedigm to Participate at the Beíjing Film Festival with Three Industry Presentations & Signing Ceremony for Cooperation Agreements with Key Chinese Entertainment Partners; 20/04/2018 – DJ Cinedigm Corp, Inst Holders, 1Q 2018 (CIDM); 09/04/2018 – Cinedigm’s 24/7 ESports-Focused WHAM Network Launches on XUMO, Twitch, and The Web Today; 26/04/2018 – Cinedigm’s Faith-Based Digital-First Network The Dove Channel Presents Kirk Cameron’s Hit Film Series REVIVE US & REVIVE US

Among 6 analysts covering Pfizer (NYSE:PFE), 3 have Buy rating, 0 Sell and 3 Hold. Therefore 50% are positive. Pfizer had 11 analyst reports since October 31, 2018 according to SRatingsIntel. The rating was upgraded by Credit Suisse to “Outperform” on Thursday, January 31. The firm has “Neutral” rating by Credit Suisse given on Wednesday, October 31. The company was maintained on Tuesday, November 6 by Citigroup. The company was downgraded on Tuesday, December 11 by JP Morgan. The stock of Pfizer Inc. (NYSE:PFE) has “Buy” rating given on Tuesday, February 19 by Cantor Fitzgerald. The stock of Pfizer Inc. (NYSE:PFE) has “Neutral” rating given on Wednesday, January 23 by UBS. Argus Research upgraded the shares of PFE in report on Thursday, January 31 to “Outperform” rating. UBS initiated Pfizer Inc. (NYSE:PFE) on Monday, February 25 with “Hold” rating. The company was downgraded on Thursday, November 1 by BMO Capital Markets.

Since January 30, 2019, it had 0 insider purchases, and 1 sale for $1.81 million activity. Another trade for 43,800 shares valued at $1.81 million was made by LANKLER DOUGLAS M on Wednesday, January 30.

Gluskin Sheff & Assoc Inc increased Madison Square Garden Co New stake by 103,244 shares to 225,531 valued at $60.38 million in 2018Q4. It also upped Dollar Tree Inc (NASDAQ:DLTR) stake by 15,782 shares and now owns 52,182 shares. Colliers Intl Group Inc was raised too.

More notable recent Pfizer Inc. (NYSE:PFE) news were published by: Seekingalpha.com which released: “Pfizer prices $5B debt offering – Seeking Alpha” on March 05, 2019, also Seekingalpha.com with their article: “FDA OKs Pfizer’s Herceptin biosimilar – Seeking Alpha” published on March 12, 2019, Seekingalpha.com published: “Pfizer Inc. (PFE) Management Presents at Cowen and Company 39th Annual Health Care Conference (Transcript) – Seeking Alpha” on March 12, 2019. More interesting news about Pfizer Inc. (NYSE:PFE) were released by: Investorplace.com and their article: “The Case Against Pfizer Stock and the Rest of the Industry – Investorplace.com” published on March 15, 2019 as well as Seekingalpha.com‘s news article titled: “Pfizer in-licenses diabetes candidate from AnTolRx – Seeking Alpha” with publication date: March 05, 2019.

Investors sentiment decreased to 0.74 in Q4 2018. Its down 0.11, from 0.85 in 2018Q3. It fall, as 42 investors sold PFE shares while 792 reduced holdings. 141 funds opened positions while 477 raised stakes. 4.05 billion shares or 2.27% more from 3.96 billion shares in 2018Q3 were reported. The Ohio-based James Inv Rech Inc has invested 1.51% in Pfizer Inc. (NYSE:PFE). 762,635 are held by Donaldson Capital Mngmt Limited Liability Company. Edge Wealth Mgmt Ltd Liability Co holds 274,403 shares. Thornburg Invest Mngmt owns 2.79 million shares. Washington Co stated it has 0.86% in Pfizer Inc. (NYSE:PFE). Birch Hill Invest Advsr Limited stated it has 54,979 shares or 0.21% of all its holdings. Bessemer Grp Inc owns 8.64M shares. Bbr Limited Liability Company has 40,473 shares for 0.23% of their portfolio. Fort Point Capital Partners Limited Company reported 0.22% stake. Narwhal Capital Mngmt invested in 183,597 shares. Hanson Doremus Inv Mgmt stated it has 122,462 shares or 1.93% of all its holdings. Amarillo Natl Bank invested 2.06% in Pfizer Inc. (NYSE:PFE). Nuveen Asset Management Limited holds 0.51% or 1.85M shares. Chicago Equity Ptnrs Ltd Limited Liability Company accumulated 0.68% or 388,691 shares. Mcdaniel Terry And Company has invested 0.15% in Pfizer Inc. (NYSE:PFE).

Analysts await Pfizer Inc. (NYSE:PFE) to report earnings on May, 7. They expect $0.77 earnings per share, 0.00% or $0.00 from last year’s $0.77 per share. PFE’s profit will be $4.27B for 13.56 P/E if the $0.77 EPS becomes a reality. After $0.64 actual earnings per share reported by Pfizer Inc. for the previous quarter, Wall Street now forecasts 20.31% EPS growth.

More notable recent Cinedigm Corp. (NASDAQ:CIDM) news were published by: Globenewswire.com which released: “Cinedigm to Acquire Future Today Inc. Nasdaq:CIDM – GlobeNewswire” on March 15, 2019, also Globenewswire.com with their article: “Cinedigm Announces Sale of 84 Digital Cinema Projection Systems – GlobeNewswire” published on February 14, 2019, Streetinsider.com published: “Cinedigm (CIDM) Regains Compliance With Nasdaq Listing Rule – StreetInsider.com” on March 04, 2019. More interesting news about Cinedigm Corp. (NASDAQ:CIDM) were released by: Nasdaq.com and their article: “Consumer Sector Update for 03/04/2019: CIDM,FTDR,ALRM,PLCE – Nasdaq” published on March 04, 2019 as well as Seekingalpha.com‘s news article titled: “Cinedigm Digital Cinema Corp (CIDM) CEO Chris McGurk on Q3 2019 Results – Earnings Call Transcript – Seeking Alpha” with publication date: February 13, 2019.

Pfizer Inc. (NYSE:PFE) Institutional Positions Chart